OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginsenoside and Its Therapeutic Potential for Cognitive Impairment
Hui Feng, Xue Mei, Hao Deng, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1310-1310
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway
Tianyao Li, Jiaxin Chen, Zhouyuan Xie, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1

Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
Kenneth Maiese
Biomolecules (2023) Vol. 13, Iss. 5, pp. 816-816
Open Access | Times Cited: 21

The Metabolic Basis for Nervous System Dysfunction in Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease
Kenneth Maiese
Current Neurovascular Research (2023) Vol. 20, Iss. 3, pp. 314-333
Open Access | Times Cited: 15

Ginsenoside Rk3 Regulates Tryptophan Metabolism along the Brain–Gut Axis by Targeting Tryptophan Hydroxylase and Remodeling the Intestinal Microenvironment to Alleviate Depressive-Like Behavior in Mice
Jingjing Shao, Linlin Qu, Yao Liu, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 13, pp. 7100-7120
Closed Access | Times Cited: 5

Inhibition of the pyroptosis-associated inflammasome pathway: The important potential mechanism of ginsenosides in ameliorating diabetes and its complications
Pan Liu, Zhengdong Zhang, Yichen Cai, et al.
European Journal of Medicinal Chemistry (2023) Vol. 253, pp. 115336-115336
Closed Access | Times Cited: 12

Cognitive Impairment in Multiple Sclerosis
Kenneth Maiese
Bioengineering (2023) Vol. 10, Iss. 7, pp. 871-871
Open Access | Times Cited: 11

Brain plasticity and ginseng
Myoung‐Sook Shin, Young‐Joo Lee, Ik‐Hyun Cho, et al.
Journal of Ginseng Research (2024) Vol. 48, Iss. 3, pp. 286-297
Open Access | Times Cited: 4

Ginsenoside Rg1 in Parkinson’s disease: from basic research to clinical applications
Qianyan Wang, Wei Lei, Guang‐Hui Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Exploring the Potential Therapeutic Approach Using Ginsenosides for the Management of Neurodegenerative Disorders
Manju, Navneeta Bharadvaja
Molecular Biotechnology (2023) Vol. 66, Iss. 7, pp. 1520-1536
Closed Access | Times Cited: 10

Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway
Lingyu She, Hao Tang, Yuqing Zeng, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117462-117462
Open Access | Times Cited: 9

Efficacy and Safety of Panax ginseng Sprout Extract in Subjective Memory Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Hyang-Im Baek, Ki-Chan Ha, Yu-Kyung Park, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1952-1952
Open Access | Times Cited: 2

New perspective on the immunomodulatory activity of ginsenosides: Focus on effective therapies for post-COVID-19
Yixin Wang, Qin Han, Shuxia Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115154-115154
Open Access | Times Cited: 6

The Role of Dietary Ingredients in Mental Energy – A Scoping Review of Randomized Controlled Trials
Kristin M. Nieman, Yong Zhu, Michelle Tucker, et al.
Journal of the American Nutrition Association (2023) Vol. 43, Iss. 2, pp. 167-182
Open Access | Times Cited: 4

Anti-leukemia effects of ginsenoside monomer: A narrative review of pharmacodynamics study
Seyyed Mohammad Matin Alavi Dana, Mohammadreza Meghdadi, Saeed Khayat Kakhki, et al.
Current Therapeutic Research (2024) Vol. 100, pp. 100739-100739
Open Access | Times Cited: 1

Artificial Intelligence and Disease Signature Pathways: Driving Innovation to Elucidate Underlying Pathogenic Mechanisms
Kenneth Maiese
Current Neurovascular Research (2024) Vol. 21, Iss. 3, pp. 229-233
Closed Access | Times Cited: 1

8-O-acetyl shanzhiside methylester protects against sleep deprivation-induced cognitive deficits and anxiety-like behaviors by regulating NLRP3 and Nrf2 pathways in mice
Yujiao Li, Xiaolu He, Jieyu Zhang, et al.
Metabolic Brain Disease (2022) Vol. 38, Iss. 2, pp. 641-655
Closed Access | Times Cited: 4

Effect of ginseng and ginsenosides on attention deficit hyperactivity disorder: A systematic review
Yunna Kim, Ik‐Hyun Cho, Seung‐Hun Cho
Journal of Ginseng Research (2024) Vol. 48, Iss. 5, pp. 437-448
Open Access

Neuroprotective Effects of Dammarane Sapogenins Against lipopolysaccharide-induced Cognitive Impairment, Neuroinflammation and Synaptic Dysfunction
Liming Dong, Ning Jiang, Jie Bai, et al.
Neurochemical Research (2023) Vol. 48, Iss. 12, pp. 3525-3537
Closed Access | Times Cited: 1

Ginsenosides in endometrium-related diseases: Emerging roles and mechanisms
Yangyang Zhang, Mao-Zhi Li, Hui‐Hui Shen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115340-115340
Open Access

Page 1 - Next Page

Scroll to top